# Frances Oldham Kelsey
قسمت های برتر پادکست
به روز شده:
Frances Kathleen Oldham Kelsey, CM (July 24, 1914 – August 7, 2015) was a Canadian-born American pharmacologist and physician. As a reviewer for the U.S. Food and Drug Administration (FDA), she refused to authorize thalidomide for market because she had concerns about the lack of evidence regarding the drug's safety. Her concerns proved to be justified when it was shown that thalidomide caused serious birth defects.
Lost Women of Science Conversations: Wonder Drug
While researching her book about thalidomide in America, Jennifer Vanderbes discovered that there were far more survivors in the U.S. than originally thought – at least ten times more. These survivors were born with shortened limbs and other serious medical conditions after their mothers unwittingl…
The Woman Who “Turned Back a Plague of Old Testament Proportions”
In refusing to approve the drug thalidomide, FDA scientist Frances Oldham Kelsey spared thousands of babies from deadly birth defects and revolutionized drug research. But was her legacy all good?Our Sponsors:* Check out ElevenReader and use my code "Spoon" for a great deal: https://elevenreader.io…
Join or Die, Grammy’s, Governor’s Ball and Bianca
Breaking News: Samie and Emily consider whether we’re all switching to LinkedIn and what Bob Ferguson thinks he’s doing.
Emily reviews the Governor’s Ball, and Samie recaps her trip to Palm Springs.
Samie recommends great books and movies, and Emily sings through her pain. They also take their cu…
How A “Petty Bureaucrat” Saved America from Thalidomide
In 1960, one woman was all that stood between American families and a medical disaster of epidemic proportions. In this episode, the story of how that woman saved untold numbers of children and how all of us today are better off for her mostly-forgotten legacy.
References
Erick, M. (n.d.). Frances…
Stalling for Survival - A Lonely Fight Against a Deadly Medicine
In 1960, FDA scientist Frances Oldham Kelsey is tasked with approving an application for a mild sedative to be sold in America. The drug is popular across Europe and is touted to be free of side effects, so this should be a routine job. But something doesn't sit right with Frances and she starts di…
Frances Oldham Kelsey
Bringing the same rigorous standards used in high quality academic research institutions to the FDA Dr. Frances Kelsey stopped the drug thalidomide from causing serve birth defects in American children and changed the drug approval process at the same time.
Image: U.S. Food and Drug Administration…
Bench Talk | Hero of the FDA - Monsanto and Israel, EPA, and Supreme Court | March 23, 2026
Dave Robinson finishes his report on Monsanto and its herbicide, Roundup. Hear how Monsanto teams up with an Israeli company to produce White Phosphorus, a toxic, incendiary tool used by the military. Find out how the Trump administration has changed the way the EPA calculates the value of a huma…
Power Misalignment: When Control Overrides Purpose
Who should power serve, and what happens when protecting a position becomes more important than the people affected? In this episode of The Third Horizon: Human Fault Lines, we examine Power Misalignment, the fifth human fault line. Through an everyday example of a manager blocking an employee’s id…
Nobel Prize in Chemistry 2026 Explained: Mirror Molecules (EP 63)
Why does life favor one molecular mirror image? The 2026 Nobel Prize in Chemistry honors Henri B. Kagan and Kenso Soai for nonlinear effects and autocatalysis in asymmetric organic synthesis.
Lester Nare and Krishna Choudhary unpack the science from first principles: chirality, Pasteur's crystals, …
موتور جستجوی پادکست
می توانید از وب سایت ما برای جستجوی پادکست های3,837,211و قسمت های197,844,774بر اساس افراد، مکان ها یا موضوعات استفاده کنید.
سرمایهگذاری روی دانش بیشترین بازده را دارد؛ پس پادکست گوش میدهم.
‐ Benjamin "Llamacorn" Franklin
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم